Dipexium Pharma (DPRX) Resumes Trading Following LUDP Halt
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Dipexium Pharma (NASDAQ: DPRX) resumed trading after LUDP halt. Shares last down 76.5%, versus down 74% prior to halt.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott (ABT) Files Complaint to Terminate Alere (ALR) Acquisition
- Alere (ALR) 30-day implied volatility at 51 into Abbott (ABT) files complaint to terminate acquisition
- Abbott (NYSE: ABT) weekly volatility elevated, into seeking to terminate acquisition of Alere
Create E-mail Alert Related CategoriesTrader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!